Community Resiliency Collective Efficacy Intervention

Sponsor
University of Pittsburgh (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05768217
Collaborator
Centers for Disease Control and Prevention (U.S. Fed)
4,600
1
2
28
164.5

Study Details

Study Description

Brief Summary

This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Community Resiliency Collective Efficacy Intervention (CRCEI)
  • Behavioral: Health Education Sessions
N/A

Detailed Description

This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of an innovative community-centered intervention that promotes thriving and resiliency to reduce community violence. In collaboration with community partners, this study will implement a Community Resiliency Collective Efficacy Intervention (CRCEI) to engage community members in dialogue on neighborhood transformation, racial and gender equity, community leadership, and organizing for social change. Facilitating discussion and community organizing within neighborhoods about child and youth thriving is expected to increase individual and neighborhood levels of collective efficacy and reduce community violence. Using a community-partnered participatory approach, this study will use a Community Thriving Matrix tool to engage youth and adult community members in ongoing dialogue on neighborhood transformation, community leadership, and organizing for social change. This focus on envisioning and creating neighborhoods in which children and adolescents can thrive is expected to translate to increased individual and neighborhood levels of collective efficacy as well as violence reduction. Comparison neighborhoods will receive health education sessions as a control intervention. The proposed study involves diverse neighborhoods in the Pittsburgh region and collecting survey data from youth (ages 13-19 years) and adult community participants (both male and female identified). Interviews with a sub-sample of community residents and facilitators and community site leads as well as observations of intervention delivery will provide qualitative information on processes of program implementation. This study will provide the first rigorous evaluation of this community-level prevention approach.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
4600 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This 2-armed cluster-randomized-controlled community-partnered project will examine the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence, Community Resiliency Collective Efficacy Intervention (CRCEI). The comparison intervention will be health education sessions, which will occur monthly as a 'light touch' intervention in control neighborhoods to recruit a similar number of community members as in the intervention neighborhoods. The study will be located in Allegheny County in Pennsylvania across 20 neighborhoods (i.e., clusters), such that assigned intervention neighborhoods (n=4) will be matched to similar comparison neighborhoods (n=4), and 12 neighborhoods will be randomized either to receive the Collective Efficacy program (i.e., intervention neighborhood, n=6) or to health sessions (comparison neighborhood, n=6). Community surveys will examine neighborhood perspectives before and after program implementation.This 2-armed cluster-randomized-controlled community-partnered project will examine the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence, Community Resiliency Collective Efficacy Intervention (CRCEI). The comparison intervention will be health education sessions, which will occur monthly as a 'light touch' intervention in control neighborhoods to recruit a similar number of community members as in the intervention neighborhoods. The study will be located in Allegheny County in Pennsylvania across 20 neighborhoods (i.e., clusters), such that assigned intervention neighborhoods (n=4) will be matched to similar comparison neighborhoods (n=4), and 12 neighborhoods will be randomized either to receive the Collective Efficacy program (i.e., intervention neighborhood, n=6) or to health sessions (comparison neighborhood, n=6). Community surveys will examine neighborhood perspectives before and after program implementation.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Community Resiliency Collective Efficacy Intervention (CRCEI) for Prevention of Community Violence - A Cluster Randomized Controlled Trial
Anticipated Study Start Date :
Mar 1, 2024
Anticipated Primary Completion Date :
Sep 29, 2025
Anticipated Study Completion Date :
Jun 30, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Community Resiliency Collective Efficacy Intervention (CRCEI)

Community Resiliency Collective Efficacy Intervention (CRCEI) to engage community members in dialogue on thriving, community leadership, and organizing for social change (9 sessions).

Behavioral: Community Resiliency Collective Efficacy Intervention (CRCEI)
The Community Resiliency Collective Efficacy Intervention (CRCEI) will involve community members in dialogue on thriving, community leadership, and organizing for social change. Participants in the intervention condition will be asked to participate in 2 sessions of discussions about community thriving and a 7-week training program on the following topics: Building on the Strengths of Your Community, Collective Efficacy and its Effects on Violence Prevention & Community Mental Health, Non-threatening Peaceful Intervention Principles and Strategies: Part One, Non-threatening Peaceful Intervention Principles and Strategies: Part Two, Safety and Roles of Police and Community in Intervening, Active/Effective listening and non-violent communication skills, and Community Resources and Indirect Intervention.

Active Comparator: Health Education Sessions

Comparison neighborhoods will receive health education sessions as a control intervention. (9 sessions)

Behavioral: Health Education Sessions
Comparison neighborhoods will receive health education sessions across a variety of community-identified health topics as a control intervention. (9 sessions)

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in perceptions of neighborhood collective efficacy and community cohesion [Change from baseline to approximately 12 months after baseline]

    Composite Measure mean score (range 1 - 5; 1 is low and 5 is best) of neighborhood-level perceptions of collective efficacy and community cohesion

Secondary Outcome Measures

  1. Community incidence of violence in 12 month period [Change from 1 year period before baseline to approximately 12 months after baseline]

    number of incidents of violence, i.e., assaults, gun violence, referrals to child protective services, compared to control neighborhoods.

  2. Community incidence of violence in 12 month period [Change from 1 year period before baseline to approximately 2 years after baseline]

    number of incidents of violence, i.e., assaults, gun violence, referrals to child protective services, compared to control neighborhoods.

  3. Change from baseline in collective efficacy and neighborhood social norms [Change from baseline to approximately 12 months after baseline]

    Composite Collective Efficacy Measure mean score (range 1-5; 1 is lowest and 5 is best) of individual-level collective efficacy and neighborhood social norms

  4. Number of self-reported events of violence exposure [Change from baseline to approximately 12 months after baseline]

    count of individual-level events of violence exposure

Eligibility Criteria

Criteria

Ages Eligible for Study:
13 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • youth age 13 years old and up (all genders)

  • adults 18 years and older (all genders)

  • reside in neighborhoods selected to participate in the study

Exclusion Criteria:
  • individuals younger than 13 years old

  • individuals residing outside of participating neighborhoods

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pittsburgh Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • University of Pittsburgh
  • Centers for Disease Control and Prevention

Investigators

  • Principal Investigator: Elizabeth Miller, MD, PhD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elizabeth Miller, Professor, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT05768217
Other Study ID Numbers:
  • STUDY22100193
  • U01CE003524-01
First Posted:
Mar 14, 2023
Last Update Posted:
Mar 22, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 22, 2023